Eko Foundation Analysis Software with Transformers (EFAST) vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Imbio (a subsidiary of 4DMedical)

AI Verdict

EFAST and Imbio PHA are adjacent healthcare AI tools, both leveraging AI in cardiology but for distinct purposes. EFAST focuses on real-time auscultation analysis for detecting structural murmurs and atrial fibrillation using digital stethoscopes. In contrast, Imbio PHA processes CT pulmonary angiogram scans to measure cardiac structures for assessing right ventricular dilation, pulmonary embolism, and hypertension.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if you require real-time, AI-powered cardiac insights during routine auscultation with a digital stethoscope. This tool is ideal for clinicians seeking immediate assistance in detecting structural murmurs and atrial fibrillation at the point of care, enabling early intervention and streamlined patient screening.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA if your workflow involves analyzing CT pulmonary angiogram (CTPA) scans for automated, precise measurements of cardiac structures. This software is best suited for radiologists and cardiologists needing to assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension from existing imaging data.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) Imbio PHA (4.0.0)
Pricing Subscription-based, contact for details Unknown
Deployment Unknown Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST emphasizes real-time AI analysis during auscultation, waveform visualization, and guided exams, seamlessly integrating with digital stethoscopes for a highly interactive point-of-care experience. This direct, hands-on approach during a patient encounter offers superior immediate usability for clinicians. Imbio PHA, while efficient, focuses on automated back-end image processing.

Clinical Value

Tie

Both tools offer significant, yet distinct, clinical value. EFAST provides real-time, high-accuracy detection of structural murmurs and atrial fibrillation during routine physical exams, potentially enabling earlier diagnosis. Imbio PHA delivers critical objective measurements from CTPA scans, aiding in the diagnosis and risk stratification of complex conditions like pulmonary embolism and hypertension.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST provides more transparency regarding its pricing model, detailing a subscription-based Eko+ membership, a free trial with stethoscope purchase, and an estimated daily cost for its hardware. In contrast, Imbio PHA only states 'contact for pricing,' offering no initial insight into its cost structure.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA offers greater deployment flexibility with options for cloud, on-premise, or partner integration, which is crucial for diverse enterprise IT environments and data governance needs. Its deep integration with native DICOM tools is also a significant advantage for radiology-focused healthcare systems. While EFAST is cloud-based and integrates with EMRs, the on-premise option gives Imbio an edge in enterprise adaptability.

Innovation

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST demonstrates a highly innovative approach by integrating real-time AI analysis directly into the traditional auscultation process using digital stethoscopes, transforming a fundamental clinical practice at the point of care. While Imbio PHA's automated image analysis is advanced, EFAST's application of AI to augment a physical exam is a more novel and disruptive innovation in clinical workflow.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health provides a comprehensive Help Center with readily accessible FAQs, user manuals, how-to videos, and troubleshooting guides, alongside multiple direct support channels including live Q&A and scheduled calls. Imbio also offers support contacts and user manuals, but Eko's broader range of immediately available self-service resources gives it a slight advantage in user support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) Imbio PHA (4.0.0)
Name Eko Foundation Analysis Software with Transformers (EFAST) Imbio PHA (4.0.0)
Company Eko Health Imbio
Description Advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.
Key Features (Cardiac-related AI) AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and Imbio PHA (4.0.0).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Foundation Analysis Software with Transformers (EFAST) assists clinicians in identifying structural murmurs and detecting atrial fibrillation during routine auscultation using digital stethoscopes. Imbio PHA (4.0.0) processes CT pulmonary angiogram (CTPA) scans to measure cardiac structures for assessing right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension.
EFAST offers AI-powered detection of structural murmurs with 93% sensitivity and 91% specificity, and atrial fibrillation detection with 95% sensitivity and 94% specificity. Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios from CTPA scans.
EFAST is designed for use in Cardiology, Family Medicine, and Internal Medicine. Imbio PHA (4.0.0) is primarily intended for Cardiology, Pulmonology, and Radiology specialties.
EFAST integrates seamlessly with Eko digital stethoscopes for real-time analysis during auscultation and offers EMR integration for streamlined documentation. Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, generating annotated DICOM images and PDF summary reports.

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.